Skip to main content
SubPopulations and InteRmediate Outcome Measures In COPD Study
SPIROMICS and SOURCE
Fall 2021 Steering Committee Meeting
Monday, October 18th & Tuesday, October 19th
11:00am – 5:00pm ET / 8:00am – 2:00pm PT
This meeting will be conducted remotely via Zoom.
DAY 1 - Monday, October 18
is open invitation to include Industry and Academic Partners.
Join via Zoom:
Meeting ID: 951 2427 8715
DAY 2 - Tuesday, October 19
is open to SPIROMICS Investigators ONLY.
SPIROMICS VIEWS WEB CHARTS
This web-based application allows users to view up-
to-date, interactive graphical displays of recruitment,
study management, and quality control.
Views Web Charts
For more information about how to log in and use the web charts, a
Please contact the GIC at
with any questions.
Recent SPIROMICS Publications
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
-- Lancet Respir Med
Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven Modules.
-- Netw Syst Med
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
-- Genome Med
Age-Dependent Associations Between 25-Hydroxy Vitamin D Levels and COPD Symptoms: Analysis of SPIROMICS.
-- Chronic Obstr Pulm Dis